(Date:11/26/2009)... Benton Communications announ... growth system for retailers struggling to make an...WEB) November 26, 2009 -- Flu fears is the type of... the emergency room, according to Dr. David Benton...eleased business growth system – The Rfacto...
(Date:11/25/2009)... , EDINA, Minn., Nov. 25 /PRNewswire-USNewswi... think of their dentist. But a chiropractor can a...or the Temporal-Mandibular Joint, which is where y...ll (temporal bone). ,, The most common symptom...ewing, clicking or popping of the jaw. But many o...
(Date:11/25/2009)... , EMERYVILLE, Calif., Nov. 25 /PRNewswire-...: ONXX ) today announced that the company will ho...iefing ,, December 7, 2009 - 9:00 a.m. CT/... discuss data presentations surrounding carfilzomi...as featured at the 51st American Society of Hemato...
(Date:11/25/2009)... , TORONTO, Nov. 25 /PRNewswire/ - Sentinelle...I coils and advanced visualization software launch...ns on its Aegis(TM) medical imaging software platf...merica (RSNA) annual meeting in Chicago, Nov. 30 -...ns leverage the unique high quality images generat...
(Date:11/25/2009)... , SILVER SPRING, Md., Nov. 25 /PRNews...M.D., director of the FDA,s Center for Drug Evalua...ain Management, Drug Safety, and the FDA," appears...rnal of Medicine. ,, (Logo: http://www.newscom... article, Woodcock discusses FDA efforts to strike...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4...tion Study Affirms Highly Automated Cardiac Safety...t , Rochester, New York (...Inc., a leading innovator in advanced cardiac safe...The study validated the use of its Highly Automate...
... Networks, Inc. has announced that it has sold the...e renaming MyBlackBook.Org, the popular sexual his... New York, NY (PRWEB) February 5...ng it,s sexual health service to nOOkist™ ( ...
...unemployment figures continue to rise, opportuniti... assisting are among the fastest-growing US occupa...emain for decades as baby boomer demographics cont... education to ophthalmic medical personnel (OMP). ...
...ce, Inc. (OTC Bulletin Board: SCIE), a San Diego b...it has entered into a $6.0 million common stock pu... a Chicago-based institutional investor. Under th...es and Exchange Commission has declared effective ...
...o Security, a Boston based venture-backed technolo... 12th Annual Wharton Entrepreneurship Conference (...preneurs to present their ideas and products to a ...er a rich context-based multi-factor authenticati...
...us Pharmaceuticals, Inc. (Nasdaq: IDEV ) (the "C...of operations for the first quarter of fiscal 2009...ted revenues of $26.4 million and a consolidated n... loss of $14.7 million or $0.19 per share for the ...
Other Medicine News:Health News:iCardiac's Highly Automated QT(sm) Technology Now Validated in Over 10 Clinical QT Studies 2Health News:iCardiac's Highly Automated QT(sm) Technology Now Validated in Over 10 Clinical QT Studies 3Health News:Resorb Networks, Inc Sells MyBlackBook Trademarks, Announces Sexual History Tracking Service's New Name, nOOkist™ 2Health News:Resorb Networks, Inc Sells MyBlackBook Trademarks, Announces Sexual History Tracking Service's New Name, nOOkist™ 3Health News:Eye Care Employment Among Fastest-Growing US Jobs 2Health News:Eye Care Employment Among Fastest-Growing US Jobs 3Health News:Eye Care Employment Among Fastest-Growing US Jobs 4Health News:SpectraScience, Inc. Enters Into $6.0 Million Common Stock Purchase Agreement 2Health News:SpectraScience, Inc. Enters Into $6.0 Million Common Stock Purchase Agreement 3Health News:Delfigo Security Selected as One of Twenty Five Most Promising Startups by The Wharton Entrepreneurship Conference 2Health News:Delfigo Security Selected as One of Twenty Five Most Promising Startups by The Wharton Entrepreneurship Conference 3Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 2Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 3Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 4Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 5Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 6Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 7Health News:Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results 8(Date:11/25/2009)..., , NEW YORK, Nov. 25 /PRNewswire/ -...earch report is available in its catalogue: ,, ...ive ,, http://www.reportlinker.com/p0164330/...e.html ,, Rising incidence of breast cancer in... principal factor influencing growth in the mammog...
(Date:11/25/2009)..., , EAST BRUNSWICK, N.J., Nov. 25 /PRNe...manufacturer of direct digital Radiography ( ddR )... been acquired by a private Swiss Investor with a ...imaging brand. The acquisition included all assets...nd inventory. After 25 years of success and growth...
(Date:11/25/2009)..., , SAN DIEGO, Nov. 25 /PRNewswire...medical device company focused on developing produ...or the spine, announced today that it will host a ...:30 p.m. ET / 2:30 p.m. PT. The conference call w...ent for the Company,s products and will include co...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8Swissray International Announces New Ownership 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4ThermoGenesis Announces Expanded Collaboration With Celling Technologies 13437 1ThermoGenesis Announces Expanded Collaboration With Celling Technologies 13437 2ThermoGenesis Announces Expanded Collaboration With Celling Technologies 13437 3ThermoGenesis Announces Expanded Collaboration With Celling Technologies 13437 4Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10 2009 13433 1Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10 2009 13433 2Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 53902 1Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 53902 2Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 53902 3...R, British Columbia, July 10, 2007 /CNW/ - Protox,...itive,top-line results from its Phase 1 clinical t..., recurrent prostate cancer,following radiation f...safe and well tolerated and shows promising signs...-prostatic,treatment. , ,"The completion of ...
...tional Phase III Study Meets Primary Endpoint in,R... to Anti-tumor,Necrosis Factor Treatments -, NUTLE...,announced that results from the Actemra Radiate (...rial successfully met its,primary endpoint in pati...(RA) who failed to respond to anti-tumor necrosis ...
Other Medicine Technology:Protox Announces Positive Clinical Data from Prostate Cancer Study 2Protox Announces Positive Clinical Data from Prostate Cancer Study 3Protox Announces Positive Clinical Data from Prostate Cancer Study 4Protox Announces Positive Clinical Data from Prostate Cancer Study 5Actemra (tocilizumab) Third Phase III Study Results Show,Significant Improvement in Symptoms of Patients with Rheumatoid,Arthritis 2Actemra (tocilizumab) Third Phase III Study Results Show,Significant Improvement in Symptoms of Patients with Rheumatoid,Arthritis 3Actemra (tocilizumab) Third Phase III Study Results Show,Significant Improvement in Symptoms of Patients with Rheumatoid,Arthritis 4